|
DNAJC13 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63780100592703E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.66462415968272E-12 |
| Normal-vs-Stage2 |
3.21469999509105E-08 |
| Normal-vs-Stage3 |
6.04459815534142E-11 |
| Normal-vs-Stage4 |
1.70890002149093E-09 |
| Stage1-vs-Stage2 |
9.102000E-01 |
| Stage1-vs-Stage3 |
5.221200E-01 |
| Stage1-vs-Stage4 |
2.040200E-01 |
| Stage2-vs-Stage3 |
7.104600E-01 |
| Stage2-vs-Stage4 |
3.074800E-01 |
| Stage3-vs-Stage4 |
4.592200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.4210854715202E-14 |
| Normal-vs-AfricanAmerican |
1.269640E-02 |
| Normal-vs-Asian |
8.77360406548178E-11 |
| Caucasian-vs-AfricanAmerican |
1.355380E-01 |
| Caucasian-vs-Asian |
1.804630E-01 |
| AfricanAmerican-vs-Asian |
5.170500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.53177512077718E-12 |
| Normal-vs-Female |
1.85584880796341E-12 |
| Male-vs-Female |
1.690630E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.12385664610792E-12 |
| Normal-vs-Age(41-60Yrs) |
5.16253706450698E-14 |
| Normal-vs-Age(61-80Yrs) |
4.32240000003414E-06 |
| Normal-vs-Age(81-100Yrs) |
1.275380E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.491600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.032150E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.285400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.351800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.729600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.992400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.960600E-01 |
| Classical-VS-Follicular |
4.467800E-01 |
| Classical-VS-Other |
1.426180E-01 |
| Classical-VS-Normal |
1.80133685745432E-12 |
| Tall-VS-Follicular |
2.367200E-01 |
| Tall-VS-Other |
2.093200E-01 |
| Tall-VS-Normal |
4.67970000528339E-08 |
| Follicular-VS-Other |
2.375500E-02 |
| Follicular-VS-Normal |
5.85829999955045E-07 |
| Other-VS-Normal |
2.81800000001553E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.51256826245117E-13 |
| Normal-vs-N1 |
1.32039934541694E-11 |
| N0-vs-N1 |
6.390100E-02 |
|
|
